HSF1 and gallbladder cancer: Collectively, these results led us to propose a model whereby CAFs-derived TSP-4 interacts with its receptor integrin α2 to activate the PI3K-Akt pathway, which results in HSF-1 activation that mediates the EMT and cancer stemness of gallbladder cancer (Fig. 9).